Shamrock Industrial Company Ltd.
Snapshot View

View in App

Prices View details >>

5.90 0.00

03 February 2023, 04:00:00 PM
Volume: 3,494

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.shamrockindustrial.wordpress.com
Market Cap 3.20 Cr.
Enterprise Value(EV) 3.20 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.29 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 32.22 Trailing Twelve Months Ending 2022-12
Book Value / Share 3.30 Trailing Twelve Months Ending 2022-12
Price to Book Value 1.79 Calculated using Price: 5.90
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.54 Cr. 5,428,414 Shares
FaceValue 10
Company Profile
Shamrock Industrial Company (SICL) is the manufacturing division of Shamrock Group of Companies, who have been primarily involved in the field of Pharmaceutical Raw Materials, Intermediates and Fine Chemicals since the past 23 years.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
+2.61%
1 Month
-5.60%
3 Month
+17.76%
6 Month
+7.08%
1 Year
-9.92%
2 Year
5 Year
10 Year

Ratios View Details >>

8 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -4.31 -105.51 -1.85 -2.17 -10.35 -8.68 -13.86 -10.36
Return on Capital Employed (%) -0.41 -21.87 -0.74 -0.85 -5.66 -8.68 -13.86 -10.36
Return on Assets (%) -0.35 -21.57 -0.73 -0.84 -5.41 -8.01 -13.58 -10.12

Balance Sheet View Details >>

Particulars 10 years 2008-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 1 1 3 3 3 3 2 2 2 2
Non Curr. Liab. 9 9 0 0
Curr. Liab. 1 2 5 5 5 0 0 0 0 0
Minority Int.
Equity & Liab. 11 11 8 8 8 3 2 2 2 2
Non Curr. Assets 8 10 8 8 8 0 0 0 0 0
Curr. Assets 4 2 0 0 0 3 2 2 2 2
Misc. Exp. not W/O
Total Assets 11 11 8 8 8 3 2 2 2 2

Profit Loss View Details >>

Particulars 10 years 2008-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 12
Other Income 2 0 0 0
Total Income 12 2 0 0 0
Total Expenditure -12 0 -3 0 0 -4 0 0 0 0
PBIDT 0 0 -2 0 0 -4 0 0 0 0
Interest 0
Depreciation 0
Taxation 0
Exceptional Items 3
PAT 0 0 -2 0 0 0 0 0 0 0
Adjusted EPS 0 0 -4 0 0 -1 0 -1 0 0

Cash Flow View Details >>

Particulars 10 years 2007-03 Rs. Cr. 2008-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -2 -9 -1 0 0
Cash Fr. Inv. 2 11
Cash Fr. Finan.
Net Change 0 0 0 2 -1 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 2 2 1 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 42.98 42.98 42.98 42.98 42.98 42.98 42.98 42.98 42.98
Public 57.02 57.02 57.02 57.02 57.02 57.02 57.02 57.02 57.02
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 31 Jan 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publications made by the Company in Active Times (English) and Mumbai Lakshadeep (Marathi) in edition dated 31.01.2023 for publication of extract of financials figures respectively in terms of Regulation 30 and 47 (1) and (3) of SEBI (LODR) Regulations 2015 in connection with its Board meeting held on 30th January 2023 for approval of Un-Audited Financial Results for quarter and nine months ended 31.12.2022.
Mon, 30 Jan 2023
Board Meeting Outcome for Submission Of Board Meeting Outcome Pursuant To Regulation 30 Of SEBI (LODR) Regulations 2015 For Board Meeting Held Today I.E On 30Th January 2023 At 4.30 Pm And Concluded At 5.10 Pm.
In terms of Regulation 30 of SEBI (LODR) Regulations 2015 this is to inform that the Meeting of the Board of Directors of the Company was held today on 30th January 2023 Monday at the Registered Office of the Company at 04.30 p.m. and concluded at 05.10 p.m. The Board discussed and approved as follows.
1. The Un-Audited Standalone Financial Results for the quarter and nine months ended 31st December 2022 along with Limited Review Report thereon under regulation 33 of SEBI (LODR) Regulations 2015 as amended.
2. Appointed / re-appointed M/s. Pankaj Trivedi & Co. Practicing Company Secretary for conducting Secretarial Audit in terms of Section 204 of the Companies Act 2013 for F.Y. 2022-23.
3. Took Note on Compliances on Listing Obligation & Disclosure Requirements Regulation 2015 for the quarter ended 31st December 2022.
Mon, 30 Jan 2023
Submission Of Brief Profile In Terms Of Circular CIR/CFD/CMD/4/2015 Dated September 9 2015 For Re-Appointment Of Secretarial Auditor In Terms Of Section 204 Of The Companies Act 2013 And Audit Under Regulation 24A Of SEBI (LODR) Regulations 2015 As Amended For F.Y. 2022-23
In terms of Regulation 30 of SEBI (LODR) Regulations 2015 this is to inform that the Meeting of the Board of Directors of the Company was held today on 30th January 2023 Monday at the Registered Office of the Company at 83-E Hansraj Pragji Building Off. Dr. E Moses Road Worli Mumbai - 400018 at 04.30 p.m. and concluded at 05.10 p.m. The Board discussed and approved the re-appointment of M/s. Pankaj Trivedi & Co. Practicing Company Secretary for conducting Secretarial Audit in terms of Section 204 of the Companies Act 2013 for F.Y. 2022-23.

Technical Scans View Details >>

Fri, 03 Feb 2023
Opening at High Opening at High
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
Closing Near 100 SMA Closing Near 100 SMA
Thu, 02 Feb 2023
Higher Delivery Quantity Higher Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On Shamrock Industrial Company Ltd.

What is Shamrock Indl. Co share price?
Can I buy Shamrock Indl. Co shares now?
What is the Market Cap of Shamrock Indl. Co?
What are the key metrics to analyse Shamrock Indl. Co?
What is the 52 Week High and Low of Shamrock Indl. Co?
What is the trend of Shamrock Indl. Co share price?